Fennec Pharmaceuticals (FENC) Other Gross PP&E Adjustments (2022 - 2024)
Historic Other Gross PP&E Adjustments for Fennec Pharmaceuticals (FENC) over the last 3 years, with Q4 2024 value amounting to -$38000.0.
- Fennec Pharmaceuticals' Other Gross PP&E Adjustments rose 4794.52% to -$38000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$38000.0, marking a year-over-year increase of 4794.52%. This contributed to the annual value of -$38000.0 for FY2024, which is 4794.52% up from last year.
- As of Q4 2024, Fennec Pharmaceuticals' Other Gross PP&E Adjustments stood at -$38000.0, which was up 4794.52% from -$73000.0 recorded in Q4 2023.
- In the past 5 years, Fennec Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of -$29000.0 in Q3 2023 and a low of -$77000.0 during Q4 2022
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$55500.0 (2023), whereas its average is -$54250.0.
- As far as peak fluctuations go, Fennec Pharmaceuticals' Other Gross PP&E Adjustments soared by 519.48% in 2023, and later skyrocketed by 4794.52% in 2024.
- Quarter analysis of 3 years shows Fennec Pharmaceuticals' Other Gross PP&E Adjustments stood at -$77000.0 in 2022, then rose by 5.19% to -$73000.0 in 2023, then skyrocketed by 47.95% to -$38000.0 in 2024.
- Its Other Gross PP&E Adjustments stands at -$38000.0 for Q4 2024, versus -$73000.0 for Q4 2023 and -$29000.0 for Q3 2023.